- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 8.78M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 8.39M sh |
| Dividends Paid | Q3 2025 · Mar 31, 2025 | $1.58M |
| Dividends Paid | Q3 2025 · Mar 31, 2024 | $1.72M |
| Capex | Q3 2025 · Mar 31, 2025 | $6K |
| Capex | Q3 2025 · Mar 31, 2024 | $3K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2025 | −$4.9M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $8.13M |
| Short Term Investments | Q3 2025 · Mar 31, 2025 | $19.7M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $9.42M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $13.6M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $134.99M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $149.04M |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | $0.05 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.27 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | $0.06 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.28 |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $2.88M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $2.9M |
| Net Income | Q3 2025 · Mar 31, 2025 | $478K |
| Net Income | Q3 2025 · Mar 31, 2024 | $2.17M |
| Operating Income | Q3 2025 · Mar 31, 2025 | −$68K |
| Operating Income | Q3 2025 · Mar 31, 2024 | $2.94M |
| Revenue | Q3 2025 · Mar 31, 2025 | $23.25M |
| Revenue | Q3 2025 · Mar 31, 2024 | $22.73M |
| Shares Outstanding restated | Q3 2025 · Oct 24, 2024 | 9.38M sh |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $123.76M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2022 | $122.45M |